stockmarket

Applied UV Tumbles After Pricing Public Offering




By Sam Boughedda

Investing.com — Applied UV Inc (NASDAQ:), the company focused on technologies that address infection prevention, saw its shares weaken Wednesday after pricing its public offering at a more than 16% discount to its closing price on Tuesday.

Applied UV shares hit a low of $2.45 following the announcement. At the time of writing, they sit 24% below Tuesday’s close at $2.71.

The company priced its underwritten offering of 2.7 million shares of common stock at $3 per share. The company plans to raise $8 million from the offering.

In addition, they have granted the underwriters a 45-day option to purchase up to an additional 400,000 shares of common stock at the public offering price. The company told investors it hopes to use the money raised for general corporate purposes, including new investments and acquisitions.

On Monday, the New York-based company announced that its CEO had resigned for personal reasons. Max Munn, founder, president and director was appointed interim CEO

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.